UK Public Sector Contracts & Tenders

The contract will initially be delivered for Northern Ireland, Wales, England, Isle of Man, Jersey, Guernsey - both NHS and Independent sector hospitals, for a period of 5 years, at a maximum total budget of up to £14,580,000 GBP including VAT, £12,150,000 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years at a potential value of £2,916,000 GBP per year including VAT, £2,430,000 GBP per year excluding VAT. These extension values are based on no aspirational intent being invoked and are therefore subject to increase proportionally to the contract value if aspiration intent is invoked. All pricing submissions must be in regard to this 'core' value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of £14,580,000 GBP including VAT, £12,150,000 GBP excluding VAT. The maximum budget ‘core’ value excludes the potential two year extension and aspirational intent as described in section C of Annex A – Service Specification Please note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is £44,027,892 GBP including VAT, £36,689,910 GBP excluding VAT There is also a potential that the contract price will be subject to discretionary inflationary uplifts. About the National Joint Registry The National Joint Registry (NJR) is the largest orthopaedic joint replacement registry in the world. It collects, analyses and reports information on joint replacement procedures to improve patient safety, support clinical decision-making, monitor implant performance and improve the quality of care across the UK and Crown Dependencies. Joint replacement surgery is one of the most successful interventions in modern healthcare, restoring mobility and reducing pain for hundreds of thousands of patients. The NJR plays a critical role in monitoring the long-term performance of joint replacement implants and surgical techniques, providing robust evidence to clinicians, healthcare organisations, regulators, patients and the orthopaedic device industry. The NJR was established in April 2002 by the Department of Health and the Welsh Government following recommendations arising from the National Audit Office investigation into the failure of the 3M Capital Hip System. Operational responsibility for the Registry transferred to the Healthcare Quality Improvement Partnership (HQIP) on 1 April 2008. The Registry has progressively expanded its scope, collecting: •hip and knee replacement data since April 2003; •ankle replacement data since April 2010; and •shoulder and elbow replacement data since April 2012. The geographical coverage of the Registry has also expanded to include: •Northern Ireland (2013); •the Isle of Man (2015); and •Guernsey (2019). •Jersey (2025) Today, the NJR contains data relating to millions of joint replacement procedures and continues to expand annually. It is recognised internationally as a leading clinical registry and provides an essential evidence base for improving outcomes, supporting research, informing procurement decisions and identifying patient safety concerns at the earliest opportunity. The NJR is funded primarily through an annual subscription model based on eligible joint replacement procedures undertaken by NHS organisations and independent healthcare providers across participating nations. Since 2014, the orthopaedic device industry has also contributed through an annual subscription supporting supplier feedback services and related reporting. Income is managed by HQIP through a dedicated NJR fund under the governance of the NJR Board. The Healthcare Quality Improvement Partnership (HQIP) is procuring a Supplier to deliver data collection, management and technology and statistical analysis and reporting. The successful Supplier will be responsible for the secure operation, maintenance and continuous development of the NJR's data management technology services and statistical analysis supporting one of the world's largest orthopaedic registries and enabling the delivery of high-quality information to patients, clinicians, healthcare providers, commissioners, regulators, researchers and the orthopaedic industry. The procurement comprises: •Core Services •NJR data collection, data management and technology solutions; statistical analysis and reporting services. HQIP is seeking a strategic delivery partner that can demonstrate: •proven expertise in delivering secure, resilient and scalable data services; •a collaborative and solution-focused approach to partnership working; •innovation and a commitment to continuous service improvement; •responsiveness, flexibility and excellent customer service; •strong governance, information security and regulatory compliance; •the ability to identify opportunities to improve efficiency, data quality and user experience; and •effective communication and stakeholder engagement. The successful Supplier will be expected to work collaboratively with HQIP to ensure seamless delivery of the Registry, maintaining continuity of service whilst supporting future innovation and development. Over the lifetime of the Contract, the Authority's ambitions include: •improving the quality, completeness and timeliness of data collection, validation and submission processes; •enhancing the resilience, scalability, performance and security of the Registry's technology platform; •increasing interoperability with NHS systems, national datasets and other relevant health and care services through open standards and modern APIs; •improving user experience through intuitive digital services, enhanced reporting capabilities and greater self-service functionality for stakeholders; •supporting more timely reporting, surveillance, analytics and insight generation to improve patient safety, clinical outcomes and service performance; •enabling the responsible adoption of automation, advanced analytics and emerging technologies, including artificial intelligence where appropriate and compliant with legal, ethical and information governance requirements; •strengthening cyber resilience, business continuity and operational sustainability; •supporting collaborative working across healthcare providers, patients, regulators, researchers, industry and other registries; •maintaining flexibility to adapt to future changes in clinical practice, regulatory requirements and national health policy; and •ensuring the Registry remains a leading international example of excellence in clinical registry management and medical device surveillance. The scope of services includes: •Collection, processing and management of registry data through direct data entry, system interfaces and other approved data submission mechanisms; •Secure hosting, storage and management of NJR data and associated information assets; •Data validation, cleansing, quality assurance and reconciliation processes to maximise data accuracy, completeness and credibility; •Data linkage, comparison and reconciliation with relevant national and international datasets; •Development, operation and enhancement of continuous monitoring and surveillance systems, including implant and patient outcome monitoring; •Statistical analysis and reporting services, including: ooutlier detection and monitoring; odevelopment and maintenance of statistical methodologies; oanalysis supporting patient safety, clinical effectiveness and service improvement; oproduction of datasets and content for the NJR Annual Report; and odelivery of ad hoc analyses and data requests as required; •Production, publication and dissemination of reports, dashboards, datasets and stakeholder information services for patients, clinicians, healthcare providers, researchers, regulators and industry partners; •Preparation and provision of research-ready datasets and support for approved research activity; •Management of data access, disclosure and information governance processes, including patient data requests, research applications and regulatory requirements; •Provision of stakeholder support services, including helpdesk functions, user support, training, communications and maintenance of stakeholder contact databases; •Hosting, maintenance, development and operation of NJR stakeholder-facing digital services, including web-based reporting and information services; and •Provision of expert advice and support on registry development, data management, analytics, clinical surveillance and emerging best practice within the UK and internationally. Further details of the existing programme can be found at: https://www.njrcentre.org.uk/

The National Emergency Laparotomy Audit (NELA) will be for NHS-funded care in England, Wales, Northern Ireland and Jersey (inclusion of other devolved nations/Crown dependencies is yet to be determined and will be detailed within the tender documentation). The initial contract is anticipated to be for a period of 3 years, at a maximum total budget of up to £ 951,168.00 excl VAT and £1,141,401.00 with VAT. Bids exceeding this limit will be rejected. Due to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a 2-year pro rata of the core 3-year funding, estimated at £634,112.00 excluding VAT. There is potential to include other Devolved Nations and/or Crown Dependencies, and aspirational measures (which will be defined in the service specification). The role of a national clinical audit is to stimulate healthcare improvement through the provision of timely and high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data can also improve the system, and there is a shared understanding of what good care looks like. The National Emergency Laparotomy Audit (NELA) was established in 2011 and has been delivered by the Royal College of Anaesthetists (RCoA) - https://www.nela.org.uk/ The overarching aim of this audit is to stimulate improvements in care for patients undergoing and not undergoing emergency laparotomy through the provision of high-quality comparative data from all providers of emergency laparotomy by measuring and reporting variations in quality of care and patient outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement by engaging with clinicians, patients and commissioners (both local and national) and regional networks. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and where there is a shared understanding of what good care looks like. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly, and appropriate tools, support and guidance accompany the data outputs. The intent is for all of these features to be implemented and improved during the period of this future contract. Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national quality improvement Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate Enable healthcare quality improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, Integrated Care System (ICS), multi-disciplinary team, possibly consultant or clinical team level and other levels of reporting Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract Ensure robust methodological and statistical input at all stages of the audit Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly. By way of example, the current contract specification includes the following anticipated benefits of the National Emergency Laparotomy Audit: National benchmarking to highlight unwarranted variation between providers Sustained reduction in 30-day mortality and postoperative complications through systematic performance monitoring against national standards Reduced length of hospital stay, supporting faster recovery and improved patient flow Increased delivery of time-critical interventions (e.g. antibiotics for sepsis, timely access to theatre), improving survival and outcomes Enhanced care for high-risk and frail patients, including improved peri-operative specialist input Shift from retrospective reporting to near real-time data and interactive dashboards Improved insight for regulators, commissioners and systems (ICSs) through consistent performance data Systematic identification and management of outliers and ‘cause for concern’, enabling early intervention Standardised performance metrics aligned with NICE and other national guidance Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data Utilise strong and effective project and programme management to deliver audit outputs on time and within budget Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services Embedded healthcare improvement plans with measurable objectives and ongoing impact evaluation Support for coordinated improvement across the entire emergency laparotomy pathway Increased use of routine data and data linkage to reduce manual data collection burden Improved data completeness, quality and efficiency, supporting robust analysis and decision-making Systematic assessment of inequalities in access, care and outcomes Support for national and local priorities to reduce inequalities and promote parity of care Active involvement of patients, carers and the public in audit design, outputs and improvement priorities Flexibility to expand scope (e.g. non-operative pathways, wider geographies including devolved nations and Crown Dependencies) Designed to evolve with emerging evidence and service models Further details of the existing audit can be found at: https://www.nela.org.uk/

The National Emergency Laparotomy Audit (NELA) will be for NHS-funded care in England, Wales, Northern Ireland and Jersey (inclusion of other devolved nations/Crown dependencies is yet to be determined and will be detailed within the tender documentation). The initial contract is anticipated to be for a period of 3 years, at a maximum total budget of up to £ 951,168.00 excl VAT and £1,141,401.00 with VAT. Bids exceeding this limit will be rejected. Due to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a 2-year pro rata of the core 3-year funding, estimated at £634,112.00 excluding VAT. There is potential to include other Devolved Nations and/or Crown Dependencies, and aspirational measures (which will be defined in the service specification). The role of a national clinical audit is to stimulate healthcare improvement through the provision of timely and high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data can also improve the system, and there is a shared understanding of what good care looks like. The National Emergency Laparotomy Audit (NELA) was established in 2011 and has been delivered by the Royal College of Anaesthetists (RCoA) - https://www.nela.org.uk/ The overarching aim of this audit is to stimulate improvements in care for patients undergoing and not undergoing emergency laparotomy through the provision of high-quality comparative data from all providers of emergency laparotomy by measuring and reporting variations in quality of care and patient outcomes. During this contract period, the successful tenderer will need to build on the achievements of the audit to date and enhance the ability for the audit to be used for healthcare improvement by engaging with clinicians, patients and commissioners (both local and national) and regional networks. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and where there is a shared understanding of what good care looks like. Data is most useful locally for healthcare improvement when its provision to clinical teams is timely, the data is refreshed regularly, and appropriate tools, support and guidance accompany the data outputs. The intent is for all of these features to be implemented and improved during the period of this future contract. Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national quality improvement Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate Enable healthcare quality improvements through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health Board, Integrated Care System (ICS), multi-disciplinary team, possibly consultant or clinical team level and other levels of reporting Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract Ensure robust methodological and statistical input at all stages of the audit Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly. By way of example, the current contract specification includes the following anticipated benefits of the National Emergency Laparotomy Audit: National benchmarking to highlight unwarranted variation between providers Sustained reduction in 30-day mortality and postoperative complications through systematic performance monitoring against national standards Reduced length of hospital stay, supporting faster recovery and improved patient flow Increased delivery of time-critical interventions (e.g. antibiotics for sepsis, timely access to theatre), improving survival and outcomes Enhanced care for high-risk and frail patients, including improved peri-operative specialist input Shift from retrospective reporting to near real-time data and interactive dashboards Improved insight for regulators, commissioners and systems (ICSs) through consistent performance data Systematic identification and management of outliers and ‘cause for concern’, enabling early intervention Standardised performance metrics aligned with NICE and other national guidance Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data Utilise strong and effective project and programme management to deliver audit outputs on time and within budget Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services Embedded healthcare improvement plans with measurable objectives and ongoing impact evaluation Support for coordinated improvement across the entire emergency laparotomy pathway Increased use of routine data and data linkage to reduce manual data collection burden Improved data completeness, quality and efficiency, supporting robust analysis and decision-making Systematic assessment of inequalities in access, care and outcomes Support for national and local priorities to reduce inequalities and promote parity of care Active involvement of patients, carers and the public in audit design, outputs and improvement priorities Flexibility to expand scope (e.g. non-operative pathways, wider geographies including devolved nations and Crown Dependencies) Designed to evolve with emerging evidence and service models Further details of the existing audit can be found at: https://www.nela.org.uk/

The National Audit of Care at the End of Life will be for NHS-funded care in England, Wales and Jersey (inclusion other devolved nations/Crown dependencies is yet to be determined and will be detailed within the tender documentation). The initial contract is anticipated to be for a period of 3 years, at a maximum total budget of up to £ 1,085,457.00 excluding VAT and £1,302,548.40 including VAT. Bids exceeding this limit will be rejected. Due to the unknowns in advance of holding the premarket engagement session, it is currently expected that the extension value will be a 2 year pro rata of the core 3 year funding, estimated at £723,638 excluding VAT. The values stated may be subject to change and the final values will be given when the tender goes live. There is potential to include other Devolved Nations and/or Crown Dependencies, and aspirational measures (which will be defined in the service specification). The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards from established professional and patient sources. Every year, over 550,000 people die in England and Wales, almost half in hospital, and in most cases death can be anticipated. There is only one chance to get care right for a dying person and those people important to them. It is essential that this is high quality and delivered compassionately by caring and competent staff. Accordingly, the National Audit of Care at the End of Life is expected to: Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract Ensure robust methodological and statistical input at all stages of the audit Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data Use strong and effective project and programme management to deliver audit outputs on time and within budget Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services The delivery of this audit is expected to include information that enables assessment of end-of-life care from multiple perspectives, including those from: Patients Bereaved people Staff The organisational context in which care is delivered The anticipated outputs are: Near real-time dynamic and interactive metric results Publication of an annual state of the nation report Quality improvement resources Resources for patients near the end of life, and those important to them The identification and notification of outliers